Medicare Enrolled
Dr. Michael Wertheim, MD
Hematology & Oncology · Fort Myers, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Wertheim from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Wertheim?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Wertheim
Dr. Michael Wertheim is a hematology & oncology specialist in Fort Myers, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Wertheim performed 45,780 Medicare services across 3,271 unique beneficiaries.
Between the years covered by Open Payments, Dr. Wertheim received a total of $156,277 from 82 pharmaceutical and/or device companies across 1224 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Wertheim is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 17% volume in FL
$156,277 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 46325 | Clear | January 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary
Medicare Utilization ↗45,780
Medicare services
Top 17% in FL for hematology & oncology
3,271
Unique beneficiaries
$10
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~2,409 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 22,440 | $0 | $2 |
| Contrast dye for imaging (iodine-based) | 4,125 | $0 | $1 |
| Denosumab injection (Prolia/Xgeva) | 3,660 | $18 | $30 |
| Dexamethasone injection (steroid) | 2,370 | $0 | $1 |
| Epoetin alfa injection (Retacrit) for anemia | 2,100 | $6 | $24 |
| Complete blood count (CBC) with differential | 1,635 | $8 | $30 |
| Epoetin alfa injection (Procrit) for anemia | 1,220 | $6 | $20 |
| Blood draw (venipuncture) | 1,164 | $8 | $15 |
| Comprehensive metabolic blood panel | 1,026 | $10 | $30 |
| Office visit, established patient (20-29 min) | 908 | $70 | $210 |
| Anti-nausea injection (Aloxi/palonosetron) | 780 | $1 | $10 |
| Office visit, established patient (30-39 min) | 350 | $98 | $300 |
| Administration of chemotherapy into vein, 1 hour or less | 278 | $104 | $330 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 263 | $24 | $85 |
| Injection of additional new drug or substance into vein | 241 | $13 | $55 |
| Ferritin level test (iron stores) | 238 | $13 | $40 |
| Iron level test | 235 | $6 | $20 |
| Iron binding capacity test | 235 | $9 | $25 |
| Drug injection, under skin or into muscle | 216 | $11 | $40 |
| Carcinoembryonic antigen (cea) protein level | 173 | $19 | $55 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 136 | $57 | $125 |
| Injection, diphenhydramine hcl, up to 50 mg | 125 | $1 | $4 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 124 | $52 | $150 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 117 | $135 | $449 |
| Folic acid level test | 115 | $14 | $55 |
| Vitamin B-12 level test | 112 | $15 | $50 |
| Administration of chemotherapy into vein, each additional hour | 104 | $23 | $80 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 103 | $20 | $60 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 95 | $17 | $50 |
| PSA test (prostate cancer screening) | 94 | $18 | $75 |
| Lactate dehydrogenase (enzyme) level | 90 | $6 | $20 |
| Hospital follow-up visit, moderate complexity | 90 | $66 | $165 |
| Prothrombin time test (blood clotting) | 81 | $4 | $15 |
| Administration of additional new drug or substance into vein, 1 hour or less | 74 | $53 | $165 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 59 | $3 | $10 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 57 | $403 | $681 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 53 | $1,175 | $5,700 |
| Infusion into a vein for hydration, each additional hour | 53 | $10 | $40 |
| Basic metabolic blood panel | 43 | $7 | $25 |
| Injection, methylprednisolone sodium succinate, up to 125 mg | 41 | $4 | $12 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 40 | $26 | $85 |
| Irrigation of implanted venous access drug delivery device | 32 | $17 | $55 |
| Ct scan of chest with contrast | 30 | $52 | $700 |
| New patient office visit, complex (60-74 min) | 30 | $168 | $520 |
| Infusion, normal saline solution , 1000 cc | 30 | $2 | $10 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 28 | $1 | $6 |
| Initial hospital admission, high complexity | 26 | $140 | $460 |
| Ct scan of abdomen and pelvis before and after contrast | 23 | $211 | $1,450 |
| Uric acid level test | 21 | $4 | $10 |
| CT scan of chest, without contrast | 19 | $45 | $375 |
| Office visit, established patient, complex (40-54 min) | 19 | $149 | $420 |
| Infusion into a vein for hydration, 31-60 minutes | 17 | $24 | $125 |
| Blood creatinine level | 15 | $5 | $15 |
| Urea nitrogen level to assess kidney function, quantitative | 15 | $4 | $7 |
| Ct scan of abdomen and pelvis without contrast | 12 | $83 | $1,075 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
50.3% high complexity
34.2% medium
15.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$156,277
Total received (2018-2024)
Avg $22,325/year across 7 years
Top 6% in FL for hematology & oncology
82
Companies
1,224
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$124,249 (79.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$19,411 (12.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,420 (7.3%)
Other
Charitable contributions, space rental, and other categories
$1,196 (0.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,571
2023
$12,080
2022
$12,627
2021
$11,802
2020
$16,044
2019
$51,033
2018
$50,119
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$42,813
Takeda Pharmaceuticals U.S.A., Inc.
$20,381
Seattle Genetics, Inc.
$12,840
Celgene Corporation
$9,701
Genentech USA, Inc.
$9,251
Amgen Inc.
$8,995
E.R. Squibb & Sons, L.L.C.
$8,639
Astellas Pharma US Inc
$6,333
Mirati Therapeutics, Inc.
$5,312
Array BioPharma Inc.
$4,451
Incyte Corporation
$4,423
PFIZER INC.
$4,103
Seagen Inc.
$3,423
Novartis Pharmaceuticals Corporation
$2,109
Daiichi Sankyo Inc.
$1,642
BeiGene USA, Inc.
$1,427
AbbVie, Inc.
$1,382
GENZYME CORPORATION
$1,305
Merck Sharp & Dohme Corporation
$657
Janssen Biotech, Inc.
$600
GlaxoSmithKline, LLC.
$457
BeiGene, Ltd.
$450
Lilly USA, LLC
$368
Janssen Scientific Affairs, LLC
$350
Merck Sharp & Dohme LLC
$273
Bayer HealthCare Pharmaceuticals Inc.
$241
AbbVie Inc.
$233
Novocure GmbH
$200
Karyopharm Therapeutics Inc.
$180
Athenex Pharmaceutical Division, LLC
$175
Dova Pharmaceuticals
$172
Boehringer Ingelheim Pharmaceuticals, Inc.
$171
EISAI INC.
$169
ABBVIE INC.
$167
Exelixis Inc.
$165
Alexion Pharmaceuticals, Inc.
$161
ARRAY BIOPHARMA INC
$151
JAZZ PHARMACEUTICALS INC.
$130
Ipsen Biopharmaceuticals, Inc
$124
Regeneron Healthcare Solutions, Inc.
$121
Gilead Sciences, Inc.
$116
SOBI, INC
$115
COMSORT, Inc
$100
Puma Biotechnology, Inc.
$97
AMAG Pharmaceuticals, Inc.
$95
Coherus Biosciences Inc.
$89
Eisai Inc.
$88
TOLMAR Pharmaceuticals, Inc.
$85
TESARO, Inc.
$83
Pharmacyclics LLC, An AbbVie Company
$83
Kite Pharma, Inc.
$79
PUMA BIOTECHNOLOGY, INC.
$76
Grifols USA, LLC
$65
G1 Therapeutics, Inc.
$61
Sobi, Inc
$58
MEDIVATION FIELD SOLUTIONS LLC
$58
Agios Pharmaceuticals, Inc.
$56
EMD Serono, Inc.
$54
TAIHO ONCOLOGY, INC.
$51
Blueprint Medicines Corporation
$49
MorphoSys, US Inc.
$44
Foundation Medicine, Inc.
$42
Sun Pharmaceutical Industries Inc.
$37
Dendreon Pharmaceuticals LLC
$31
Aveo Pharmaceuticals, Inc.
$29
Aurobindo Pharma USA, Inc.
$29
Taiho Oncology, Inc.
$26
Jazz Pharmaceuticals Inc.
$24
AVEO Pharmaceuticals, Inc.
$23
Teva Pharmaceuticals USA, Inc.
$19
Cumberland Pharmaceuticals, Inc.
$18
Mylan Institutional Inc.
$17
Janssen Pharmaceuticals, Inc
$16
Acceleron Pharma, Inc.
$15
Kyowa Kirin, Inc.
$15
Tolmar, Inc.
$15
R-Pharm US LLC
$14
Advanced Accelerator Applications
$13
Amneal Pharmaceuticals LLC
$13
Shire North American Group Inc
$12
INSYS Therapeutics Inc
$12
Heron Therapeutics, Inc.
$11
Top 3 companies account for 48.7% of total payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AFINITOR · ALIMTA · ALUNBRIG · AVASTIN · Abraxane · Alecensa · Avastin · BAVENCIO · BENDEKA · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Braftovi · CABLIVI · CABOMETYX · CALQUENCE · CARVYKTI · COSELA · CYRAMZA · Cabometyx · DARZALEX · DAURISMO · DOPTELET · Doptelet · ELIGARD · ELIQUIS · ELITEK · EMPLICITI · ENHERTU · ENJAYMO · ERBITUX · ERLEADA · EXKIVITY · Enhertu · FERAHEME · FOTIVDA · FOUNDATIONONE · Folotyn · Fulphila · GAMMAGARD · GAVRETO · GAZYVA · GILOTRIF · Gamunex-C · Herceptin · IBRANCE · ICLUSIG · IDHIFA · IMBRUVICA · IMFINZI · INFLECTRA · INJECTAFER · INLYTA · INREBIC · Imbruvica · Ixempra · JADENU · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUPRON DEPOT · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lupron Depot · Lutathera · MEKINIST · MONJUVI · MVASI · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · OJJAARA · ONUREG · OPDIVO · OPDUALAG · Onivyde · PADCEV · PLUVICTO · POTELIGEO · PROMACTA · PROVENGE · Perjeta · Phesgo · Pomalyst · Prolia · REBLOZYL · RETEVMO · ROZLYTREK · Reblozyl · Revlimid · SANCUSO · SARCLISA · SELZENTRY · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · SUSTOL · SUTENT · SYNDROS · Somatuline Depot · Stivarga · TABRECTA · TAGRISSO · TALVEY · TASIGNA · TECENTRIQ · TECVAYLI · TEVIMBRA · TIBSOVO · TUKYSA · Tazverik · Tecentriq · ULTOMIRIS · Udenyca · Ultomiris · VELCADE · VENCLEXTA · VERZENIO · VOTRIENT · Vectibix · Venclexta · XALKORI · XARELTO · XGEVA · XOSPATA · XPOVIO · XTANDI · Xofigo · Xtandi · YONSA · ZEJULA · ZEPZELCA · ZYTIGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (80%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in hematology & oncology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 6% for hematology & oncology in FL.
Equivalent to $341 per 100 Medicare services performed
Geographic Context
Hematology & oncology specialists within 10 mi
11
Per 100K population
1.4
County median income
$73,099
Nearest hospital
LEE MEMORIAL HOSPITAL
8.0 mi
8.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Wertheim is a mixed practice specialist, with above-average Medicare volume (top 17% in FL), with speaking/promotional industry engagement in the top 6% of FL peers, with 19 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Wertheim experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Wertheim performed 22,440 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Wertheim receive payments from pharmaceutical companies?
Yes. Dr. Wertheim received a total of $156,277 from 82 companies across 1,224 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Wertheim's costs compare to other hematology & oncology specialists in Fort Myers?
Dr. Wertheim's average Medicare payment per service is $10. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Wertheim) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Fort Myers
Browse hematology & oncology specialists in Fort Myers ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in FL
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in FL
Which FL hematology & oncology specialists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Takeda Pharmaceuticals U.S.A., Inc. Payments to Doctors
See all physicians who received payments from Takeda Pharmaceuticals U.S.A., Inc.
By company
Seattle Genetics, Inc. Payments to Doctors
See all physicians who received payments from Seattle Genetics, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology